Related Experiment Videos
Quarterly intravenous ibandronate for postmenopausal osteoporosis
1Emkey Osteoporosis & Arthritis Clinic, 1235 Penn Avenue, Suite 200, Wyomissing, PA 19610, USA. bonedocron@yahoo.com
Quarterly intravenous ibandronate injections offer superior osteoporosis treatment for postmenopausal women compared to oral bisphosphonates. This method improves bone density and fracture prevention with a favorable safety profile.
Area of Science:
- Endocrinology
- Pharmacology
- Bone Metabolism
Background:
- Osteoporosis is prevalent and undertreated in postmenopausal women.
- Nitrogen-containing bisphosphonates are primary pharmacotherapy for osteoporosis.
- Oral bisphosphonates necessitate strict adherence to dosing for efficacy and safety.
Purpose of the Study:
- To review the efficacy, safety, and tolerability of quarterly intravenous ibandronate 3 mg injections.
- To compare intravenous ibandronate with oral bisphosphonate therapy.
Main Methods:
- Review of clinical data on quarterly intravenous ibandronate 3 mg.
- Analysis of bone mineral density (BMD) changes and fracture incidence.
- Assessment of safety and tolerability, including renal profile and atrial fibrillation events.
Main Results:
- Quarterly intravenous ibandronate demonstrated superior efficacy in increasing bone mineral density compared to daily oral ibandronate.
- Intravenous ibandronate was associated with improved fracture prevention.
- No drug-related serious atrial fibrillation events were reported with intravenous ibandronate.
- The intravenous regimen showed a favorable renal safety profile.
Conclusions:
- Quarterly intravenous ibandronate is an effective and safe option for osteoporosis management in postmenopausal women.
- This administration route offers a beneficial alternative for patients unable to tolerate oral bisphosphonates.
- The simple, quick injection procedure enhances patient compliance and convenience.
Related Concept Videos
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Urinary Tract Calculi III: Medical Management